Comparative Study of Latanoprost Drug Delivery Systems for Glaucoma Treatment and Their Interaction with the Tear Film Lipid Layer Models
- 18 December 2023
- journal article
- research article
- Published by American Chemical Society (ACS) in Molecular Pharmaceutics
- Vol. 21 (1) , 126-136
Abstract
This study investigates the interaction of two approved and one newly developed latanoprost formulation with in vitro and in silico models of the tear film and tear film lipid layer (TFLL). Latanoprost, a prostaglandin analogue used for intraocular elevated pressure treatment, is topically delivered by nanocarriers within aqueous solutions or emulsions. The study focuses on the impact of these carriers on drug interactions with the tear film and their effect on the TFLL. Three different types of latanoprost carriers, micellar, nanoemulsion, and polymer-based, were compared, and each revealed distinct interaction patterns with the TFLL. Surface pressure kinetics demonstrated a rapid increase for the benzalkonium chloride formulation and a slow rise for the preservative-free variants. Visualization of the acellular in vitro TFLL model revealed different patterns of incorporation for each formulation, indicating unique interaction mechanisms. Molecular dynamics simulations further revealed different mechanisms of drug release in the TFLL between micellar and nanoemulsion formulations. In-depth examination highlighted the role of triglyceride molecules in replenishing the nonpolar layer of the TFLL, which suggests potential improvements in ocular surface compatibility by adjusting the quality and concentration of the oily phase. These findings suggest the potential for optimizing latanoprost formulations by tuning the oily phase-to-surfactant ratio and selecting suitable surfactants.Keywords
Funding Information
- Grantov? Agentura Cesk? Republiky (21-19854S)
This publication has 27 references indexed in Scilit:
- Recent advances in topical ophthalmic drug delivery with lipid-based nanocarriersDrug Discovery Today, 2013
- Efficacy and safety of preservative-free latanoprost eyedrops, compared with BAK-preserved latanoprost in patients with ocular hypertension or glaucomaBritish Journal of Ophthalmology, 2012
- A Comparative Study of a Preservative-Free Latanoprost Cationic Emulsion (Catioprost) and a BAK-Preserved Latanoprost Solution in Animal ModelsJournal of Ocular Pharmacology and Therapeutics, 2012
- Successfully Improving Ocular Drug Delivery Using the Cationic Nanoemulsion, NovasorbJournal of Drug Delivery, 2012
- The MARTINI Force Field: Coarse Grained Model for Biomolecular SimulationsThe Journal of Physical Chemistry B, 2007
- Canonical sampling through velocity rescalingThe Journal of Chemical Physics, 2007
- GROMACS: Fast, flexible, and freeJournal of Computational Chemistry, 2005
- Cyclodextrins in ophthalmic drug deliveryAdvanced Drug Delivery Reviews, 1999
- VMD: Visual molecular dynamicsJournal of Molecular Graphics, 1996
- The ocular pharmacokinetics of eicosanoids and their derivatives. 1. Comparison of ocular eicosanoid penetration and distribution following the topical application of PGF2α, PGF2α-1-methyl ester, and PGF2α-1-isopropyl esterExperimental Eye Research, 1987